390 related articles for article (PubMed ID: 31184718)
1. Safer CAR T-Cell Therapy.
Abbasi J
JAMA; 2019 Jun; 321(22):2155. PubMed ID: 31184718
[No Abstract] [Full Text] [Related]
2. CAR T cells - what have we learnt?
Nat Rev Clin Oncol; 2017 Dec; 15(1):1. PubMed ID: 29242589
[No Abstract] [Full Text] [Related]
3. Beginning the CAR T cell therapy revolution in the US and EU.
Grupp S
Curr Res Transl Med; 2018 May; 66(2):62-64. PubMed ID: 29656949
[No Abstract] [Full Text] [Related]
4. Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy.
Gauthier J; Turtle CJ
Curr Res Transl Med; 2018 May; 66(2):50-52. PubMed ID: 29625831
[TBL] [Abstract][Full Text] [Related]
5. Chimeric antigen receptor modified T cell therapy in B cell non-Hodgkin lymphomas.
Levin A; Shah NN
Am J Hematol; 2019 May; 94(S1):S18-S23. PubMed ID: 30652353
[TBL] [Abstract][Full Text] [Related]
6. The use of chimeric antigen T-cell therapy in chronic lymphocytic leukemia.
Siddiqi T
Clin Adv Hematol Oncol; 2022 Jun; 20(6):366-368. PubMed ID: 35731607
[No Abstract] [Full Text] [Related]
7. The acceleration of CAR-T therapy in non-Hodgkin lymphoma.
Munshi PN; Ujjani C
Hematol Oncol; 2019 Aug; 37(3):233-239. PubMed ID: 30427551
[TBL] [Abstract][Full Text] [Related]
8. Research Techniques Made Simple: CAR T-Cell Therapy.
Siddiqi HF; Staser KW; Nambudiri VE
J Invest Dermatol; 2018 Dec; 138(12):2501-2504.e1. PubMed ID: 30243656
[TBL] [Abstract][Full Text] [Related]
9. [Not Available].
Gauthier J
Bull Cancer; 2018 Dec; 105 Suppl 2():S214-S217. PubMed ID: 30686360
[TBL] [Abstract][Full Text] [Related]
10. CAR T cells: The future is already present.
Sánchez-Escamilla M; Yáñez San Segundo L; Urbano-Ispizua Á; Perales MÁ
Med Clin (Barc); 2019 Apr; 152(7):281-286. PubMed ID: 30392694
[No Abstract] [Full Text] [Related]
11. Chimeric antigen receptor T-cell therapy hits the market.
Boyer MW
Immunotherapy; 2018 Aug; 10(11):911-912. PubMed ID: 30149765
[No Abstract] [Full Text] [Related]
12. Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL.
Rejeski K; Wu Z; Blumenberg V; Kunz WG; Müller S; Kajigaya S; Gao S; Bücklein VL; Frölich L; Schmidt C; von Bergwelt-Baildon M; Feng X; Young NS; Subklewe M
Blood; 2022 Nov; 140(20):2175-2179. PubMed ID: 35776908
[TBL] [Abstract][Full Text] [Related]
13. CAR T-cell therapy: Full speed ahead.
Sermer D; Brentjens R
Hematol Oncol; 2019 Jun; 37 Suppl 1():95-100. PubMed ID: 31187533
[TBL] [Abstract][Full Text] [Related]
14. CAR T-cell therapy: perceived need versus actual evidence.
The Lancet Oncology
Lancet Oncol; 2018 Oct; 19(10):1259. PubMed ID: 30303110
[No Abstract] [Full Text] [Related]
15. Managing the toxicities of CAR T-cell therapy.
Neelapu SS
Hematol Oncol; 2019 Jun; 37 Suppl 1():48-52. PubMed ID: 31187535
[TBL] [Abstract][Full Text] [Related]
16. Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia.
Prommersberger S; Jetani H; Danhof S; Monjezi R; Nerreter T; Beckmann J; Einsele H; Hudecek M
Curr Res Transl Med; 2018 May; 66(2):37-38. PubMed ID: 29655962
[No Abstract] [Full Text] [Related]
17. The promise of CAR T-cell therapy in aggressive B-cell lymphoma.
Nair R; Neelapu SS
Best Pract Res Clin Haematol; 2018 Sep; 31(3):293-298. PubMed ID: 30213399
[TBL] [Abstract][Full Text] [Related]
18. Advances in off-the-shelf CAR T-cell therapy.
Benjamin R
Clin Adv Hematol Oncol; 2019 Mar; 17(3):155-157. PubMed ID: 30969953
[No Abstract] [Full Text] [Related]
19. Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives.
Gauthier J; Yakoub-Agha I
Curr Res Transl Med; 2017 Sep; 65(3):93-102. PubMed ID: 28988742
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement.
Ryan CE; Zon RL; Redd R; Fisher DC; Shouval R; Kumar A; Crombie JL; Sadrzadeh H; Kim AI; Nayak L; Chukwueke UN; Jacobson CA; Frigault MJ; Palomba ML; Armand P; Epstein-Peterson Z; Merryman RW
Br J Haematol; 2023 Dec; 203(5):774-780. PubMed ID: 37584155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
